Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Venous Thromboembolism 1Supratentorial Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neoplasm Metastasis 1Glioma 1Endometrial Neoplasms 1Dyskinesias 1Diarrhea 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Probiotics 2Fecal Microbiota Transplantation 2shosaiko-to 1maltodextrin 1bile acid binding proteins 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Raloxifene Hydrochloride 1Loperamide 1Long-Term Synaptic Depression 1Diet Therapy 1Calcium Aluminosilicate 1Anti-Bacterial Agents 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Diarrhea × Long-Term Synaptic Depression × Clear all
NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Guangzhou University of Traditional Chinese Medicine

Phase NA Completed
24 enrolled

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡